Your account is not claimed yet. You can sign up with ORCID to claim your account.

Anastasia A Pantazaki (A A Pantazaki)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 10

Top Venues

Applied microbiology and biotechnology

EMBO reports

Dalton transactions (Cambridge, England : 2003)

Pharmaceutics

Aristotle University of Thessaloniki

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Aristotle University of Thessaloniki Oct 29o 1990

Greece

Professor :: School of Chemistry

Publications

Dimitrios I Avgoulas, Konstantinos S Tasioulis, Rigini M Papi, Anastasia A Pantazaki
Therapeutic and Diagnostic Potential of Exosomes as Drug Delivery Systems in Brain Cancer. Pharmaceutics 15 (5) (2023)
Georgios Katsipis, Anastasia A Pantazaki
Serrapeptase impairs biofilm, wall, and phospho-homeostasis of resistant and susceptible Staphylococcus aureus. Applied microbiology and biotechnology 107 (4) (2023)
Georgios Katsipis, Anastasia A Pantazaki
Serrapeptase impairs biofilm, wall, and phospho-homeostasis of resistant and susceptible Staphylococcus aureus. Applied microbiology and biotechnology 107 (4) (2023)
Georgios Katsipis, Anastasia A Pantazaki
Serrapeptase impairs biofilm, wall, and phospho-homeostasis of resistant and susceptible Staphylococcus aureus. Applied microbiology and biotechnology 107 (4) (2023)
Georgios Katsipis, Anastasia A Pantazaki
Serrapeptase impairs biofilm, wall, and phospho-homeostasis of resistant and susceptible Staphylococcus aureus. Applied microbiology and biotechnology 107 (4) (2023)
Georgios Katsipis, Anastasia A Pantazaki
Serrapeptase impairs biofilm, wall, and phospho-homeostasis of resistant and susceptible Staphylococcus aureus. Applied microbiology and biotechnology (2023)
Georgios Katsipis, Dimitrios I Avgoulas, George D Geromichalos, Maria Petala, Anastasia A Pantazaki
In vitro and in silico evaluation of the serrapeptase effect on biofilm and amyloids of Pseudomonas aeruginosa. Applied microbiology and biotechnology (2023)
Angelos Papaspyropoulos, Andriani Angelopoulou, Ioanna Mourkioti, Aikaterini Polyzou, Daniela Pankova, Konstantinos Toskas, Simone Lanfredini, Anastasia A Pantazaki, Nefeli Lagopati, Athanassios Kotsinas, Konstantinos Evangelou, Efstathios Chronopoulos, Eric O'Neill, Vassilis G Gorgoulis
RASSF1A disrupts the NOTCH signaling axis via SNURF/RNF4-mediated ubiquitination of HES1. EMBO reports 23 (2) (2021)
Eleftherios Halevas, Barbara Mavroidi, Orestis Antonoglou, Antonios Hatzidimitriou, Marina Sagnou, Anastasia A Pantazaki, George Litsardakis, Maria Pelecanou
Structurally characterized gallium-chrysin complexes with anticancer potential. Dalton transactions (Cambridge, England : 2003) 49 (8) (2020)
G Katsipis, V Tsalouxidou, E Halevas, E Geromichalou, G Geromichalos, Anastasia A Pantazaki
In vitro and in silico evaluation of the inhibitory effect of a curcumin-based oxovanadium (IV) complex on alkaline phosphatase activity and bacterial biofilm formation. Applied microbiology and biotechnology 105 (1) (2020)

Anastasia A Pantazaki.css-eqlu8i{font-size:small;padding-left:4px;} (A A Pantazaki)

Publication Activity (10 Years)

Top Topics

Top Venues

Anastasia A Pantazaki (A A Pantazaki)